Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma

doi:10.3748/wjg.v25.i48.6902

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7160)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

398

WORD

249

HTML

4276

Figures (1-4)

311

Tables (1-6)

275

Sum=5509

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

678

Download

973

Sum=1651

Dec 28, 2019 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Dec 28, 2019; 25(48): 6902-6915
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6902

Full Size Figure Download Figure

Figure 1 Cancer susceptibility candidate 9 expression and survival from TCGA database. A: Cancer susceptibility candidate 9 (CASC9) was highly expressed in cancer patients; B: The survival rate of the high CASC9 expression group was lower than that of the low CASC9 expression group (P = 0.011). ^bP < 0.01. CASC9: Cancer susceptibility candidate 9.

Citation: Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol 2019; 25(48): 6902-6915
URL: https://www.wjgnet.com/1007-9327/full/v25/i48/6902.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i48.6902